Trans Tasman Radiation Oncology Group
35 clinical trials · Sponsor
◉ Watch Trans Tasman Radiation Oncology Group
| Record | Firm | Date |
|---|---|---|
| Primary Radiotherapy In MEtastatic Lung Cancer (NCT07135882) | Trans Tasman Radiation Oncology Group | 2026-08-25 |
| Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy (NCT05796089) | Trans Tasman Radiation Oncology Group | 2022-01-01 |
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (NCT04319783) | Trans Tasman Radiation Oncology Group | 2021-06-02 |
| A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer (NCT02898727) | Trans Tasman Radiation Oncology Group | 2017-11-20 |
Track Trans Tasman Radiation Oncology Group automatically
Every clearance here is in the API, with alerts when new ones post.